Description: Sirona Biochem is a biotechnology company developing diabetes therapeutics, skin depigmenting and anti-aging agents for cosmetic use, biological ingredients and cancer vaccine antigens. The company utilizes a proprietary chemistry technique to improve pharmaceutical properties of carbohydrate-based molecules.
Home Page: www.sironabiochem.com
595 Burrard Street
Vancouver,
BC
V7X 1L4
Canada
Phone:
604 641 4466
Officers
| Name | Title |
|---|---|
| Dr. Howard J. Verrico M.D., Ph.D. | Founder, Chairman, CEO & Sec. |
| Mr. Christopher D. Hopton C.G.A., C.P.A. | CFO & Director |
| Dr. Géraldine Deliencourt-Godefroy Ph.D. | Chief Scientific Officer & Director |
| Ms. Michelle Seltenrich MBA | VP of Operations |
| Dr. Brett A. Premack Ph.D. | Scientific Consultant |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 36.9307 |
| Price-to-Sales TTM: | 36.4594 |
| IPO Date: | |
| Fiscal Year End: | October |
| Full Time Employees: | 0 |